More than 30,000 people in the United States and 60,000 Europeans
will learn that they have pancreatic cancer this year.
The Pancreatic Duct is intended to offer a solid introduction
to pancreatic cancer. It is intended to provide credible information
about pancreatic cancer to enable the patient and their loved
ones to learn about the disease. To help them to understand and
better accept what is happening to them. And to help them participate
effectively as an active part of their health care team.
Information about the founder of this site and his experiences
with pancreatic cancer are located in the Founder
section.
Chemoradioimmunotherapy in
Locally Advanced Pancreatic and Biliary Tree Adenocarcinoma:
A Multicenter Phase II Study.
Recchia F, Sica G, Candeloro
G, Bisegna R, Bratta M, Bonfili P, Necozione S, Tombolini V,
Rea S.
Pancreas. 2009 Aug;38(6):e163-8. [Epub June 12]. Unità
Operativa di Oncologia, Ospedale Civile di Avezzano, Italy.
[Link
to Abstract]
Rationale for an Intraperitoneal
Gemcitabine Chemotherapy Treatment for Patients with Resected
Pancreatic Cancer.
Kamath A, Yoo D, Stuart
OA, Bijelic L, Sugarbaker PH.
Recent Pat Anticancer Drug Discov. 2009 Jun;4 (2):174-9. Washington
Cancer Institute, Washington, DC.
[Link
to Abstract]
Staged Surgery with Neoadjuvant
(90)Y-DOTATOC Therapy for Down-sizing Synchronous Bilobular Hepatic
Metastases from a Neuroendocrine Pancreatic Tumor.
Stoeltzing O, Loss M,
Huber E, Gross V, Eilles C, Mueller-Brand J, Schlitt HJ.Langenbecks
Arch Surg.2009. [Epub Jun 9]. University of Regensburg Medical
Center, Germany.
[Link
to Abstract]
Successful Control of Intractable
Hypoglycemia Using Rapamycin in an 86-Year Old Man with A Pancreatic
Insulin-Secreting Islet Cell Tumor and Metastases.
Bourcier ME, Sherrod
A, Diguardo M, Vinik AI.
J Clin Endocrinol Metab. 2009. [Epub Jun 30]. Eastern Virginia
Medical School, Norfolk, Virginia.
[Link
to Abstract]
